I talked to PTX ...The last update was 15 September and it was stated that the the AML trial was imminent.I was told that we are currently going through the screening process and it was very detailed...very important to have the right patients to give the trial every chance of success...this procedure does lead to delays.
It will be announced to the market when the first patient is dosed.
Ann: Rodman & Renshaw Global Investment conference Presentation-PTX.AX, page-52
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
